发明名称 |
CD86 antagonist multi-target binding proteins |
摘要 |
This disclosure provides a multi-specific fusion protein composed of a CD86 antagonist binding domain and another binding domain that is an IL-10 agonist, an HLA-G agonist, an HGF agonist, an IL-35 agonist, a PD-1 agonist, a BTLA agonist, a LIGHT antagonist, a GITRL antagonist or a CD40 antagonist. The multi-specific fusion protein may also include an intervening domain that separates the other domains. This disclosure also provides polynucleotides encoding the multi-specific fusion proteins, compositions of the fusion proteins, and methods of using the multi-specific fusion proteins and compositions. |
申请公布号 |
US9493564(B2) |
申请公布日期 |
2016.11.15 |
申请号 |
US200913122383 |
申请日期 |
2009.10.02 |
申请人 |
APTEVO RESEARCH AND DEVELOPMENT LLC |
发明人 |
Thompson Peter Armstrong;Baum Peter Robert;Tan Philip;Blankenship John W.;Natarajan Sateesh Kumar |
分类号 |
A61K39/00;C07K16/28;A61K39/395 |
主分类号 |
A61K39/00 |
代理机构 |
Cooley LLP |
代理人 |
Cooley LLP |
主权项 |
1. A multi-specific fusion protein, comprising a CD86 binding domain linked to a heterologous binding domain by an intervening domain, wherein the heterologous binding domain is an IL-10 or a monoIL10 that is an IL-10 molecule having a short linker that separates two subdomains of the IL-10 molecule, and wherein the CD86 binding domain comprises heavy chain and light chain variable regions of a CD86-specific antibody binding domain. |
地址 |
Seattle WA US |